Search

Author/Creator Wolf, Max

1. A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial. Issue 5 (21st February 2014)

Authors:
Hertzberg, Mark; Matthews, Jane Palfrey; Stone, Janey Malka; Dubosq, Ming‐Celine; Grigg, Andrew; Ellis, David; Benson, Warwick; Browett, Peter; Horvath, Noemi; Januszewicz, Henry; Abdi, Ehtesham; Green, Michael; Bonaventura, Anthony; Marlton, Paula; Cannell, Paul; Wolf, Max
Journal:
American journal of hematology
Issue:
Volume 89:Issue 5(2014:May)
Page Start:
536
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Issue 7 (1st July 2013)

Authors:
Wong Doo, Nicole; Thompson, Philip A.; Prince, H. Miles; Seymour, John F.; Ritchie, David; Stokes, Kerrie; Burbury, Kate; Wolf, Max; Joyce, Trish; Harrison, Simon J.
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 7(2013:Jul.)
Page Start:
1465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. Issue 7 (July 2013)

Authors:
Wong Doo, Nicole; Thompson, Philip A.; Prince, H. Miles; Seymour, John F.; Ritchie, David; Stokes, Kerrie; Burbury, Kate; Wolf, Max; Joyce, Trish; Harrison, Simon J.
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 7(2013:Jul.)
Page Start:
1465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy. Issue 5 (3rd May 2016)

Authors:
Lew, Thomas E.; Cheah, Chan Y.; Carney, Dennis A.; Prince, H. Miles; Wolf, Max; Bazargan, Ali; Januszewicz, E. Henry; Filshie, Robin; Westerman, David; Seymour, John F.; Tam, Constantine S.
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 5(2016:May)
Page Start:
1044
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗